Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury

Koichi Fukunaga, Payal Kohli, Caroline Bonnans, Laura E. Fredenburgh, Bruce D. Levy

Research output: Contribution to journalArticle

196 Citations (Scopus)

Abstract

Acute lung injury (ALI) is a severe illness with excess mortality and no specific therapy. In its early exudative phase, neutrophil activation and accumulation in the lung lead to hypoxemia, widespread tissue damage, and respiratory failure. In clinical trials, inhibition of proinflammatory mediators has not proven effective. In this study, we pursued a new investigative strategy that emphasizes mediators promoting resolution from lung injury. A new spontaneously resolving experimental murine model of ALI from acid aspiration was developed to identify endogenous proresolving mechanisms. ALI increased cyclooxygenase 2 (COX-2) expression in murine lung. Selective pharmacologic inhibition or gene disruption of COX-2 blocked resolution of ALI. COX-2-derived products increased levels of the proresolving lipid mediators lipoxin A 4 (LXA4) and, in the presence of aspirin, 15-epi-LXA 4. Both LXA4 and 15-epi-LXA4 interact with the LXA4 receptor (ALX) to mediate anti-inflammatory actions. ALX expression was markedly induced by acid injury and transgenic mice with increased ALX expression displayed dramatic protection from ALI. Together, these findings indicate a protective role in ALI for COX-2-derived mediators, in part via enhanced lipoxin signaling, and carry potential therapeutic implications for this devastating clinical disorder.

Original languageEnglish
Pages (from-to)5033-5039
Number of pages7
JournalJournal of Immunology
Volume174
Issue number8
Publication statusPublished - 2005 Apr 15
Externally publishedYes

Fingerprint

Acute Lung Injury
Cyclooxygenase 2
Lipoxins
Lung
Neutrophil Activation
Acids
Lung Injury
Respiratory Insufficiency
Transgenic Mice
Aspirin
Anti-Inflammatory Agents
Theoretical Models
Clinical Trials
Lipids
Mortality
Wounds and Injuries
Therapeutics
Genes

ASJC Scopus subject areas

  • Immunology

Cite this

Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L. E., & Levy, B. D. (2005). Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. Journal of Immunology, 174(8), 5033-5039.

Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. / Fukunaga, Koichi; Kohli, Payal; Bonnans, Caroline; Fredenburgh, Laura E.; Levy, Bruce D.

In: Journal of Immunology, Vol. 174, No. 8, 15.04.2005, p. 5033-5039.

Research output: Contribution to journalArticle

Fukunaga, K, Kohli, P, Bonnans, C, Fredenburgh, LE & Levy, BD 2005, 'Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury', Journal of Immunology, vol. 174, no. 8, pp. 5033-5039.
Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. Journal of Immunology. 2005 Apr 15;174(8):5033-5039.
Fukunaga, Koichi ; Kohli, Payal ; Bonnans, Caroline ; Fredenburgh, Laura E. ; Levy, Bruce D. / Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. In: Journal of Immunology. 2005 ; Vol. 174, No. 8. pp. 5033-5039.
@article{c6da7425b59d4026bf0f1b886624ef1a,
title = "Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury",
abstract = "Acute lung injury (ALI) is a severe illness with excess mortality and no specific therapy. In its early exudative phase, neutrophil activation and accumulation in the lung lead to hypoxemia, widespread tissue damage, and respiratory failure. In clinical trials, inhibition of proinflammatory mediators has not proven effective. In this study, we pursued a new investigative strategy that emphasizes mediators promoting resolution from lung injury. A new spontaneously resolving experimental murine model of ALI from acid aspiration was developed to identify endogenous proresolving mechanisms. ALI increased cyclooxygenase 2 (COX-2) expression in murine lung. Selective pharmacologic inhibition or gene disruption of COX-2 blocked resolution of ALI. COX-2-derived products increased levels of the proresolving lipid mediators lipoxin A 4 (LXA4) and, in the presence of aspirin, 15-epi-LXA 4. Both LXA4 and 15-epi-LXA4 interact with the LXA4 receptor (ALX) to mediate anti-inflammatory actions. ALX expression was markedly induced by acid injury and transgenic mice with increased ALX expression displayed dramatic protection from ALI. Together, these findings indicate a protective role in ALI for COX-2-derived mediators, in part via enhanced lipoxin signaling, and carry potential therapeutic implications for this devastating clinical disorder.",
author = "Koichi Fukunaga and Payal Kohli and Caroline Bonnans and Fredenburgh, {Laura E.} and Levy, {Bruce D.}",
year = "2005",
month = "4",
day = "15",
language = "English",
volume = "174",
pages = "5033--5039",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury

AU - Fukunaga, Koichi

AU - Kohli, Payal

AU - Bonnans, Caroline

AU - Fredenburgh, Laura E.

AU - Levy, Bruce D.

PY - 2005/4/15

Y1 - 2005/4/15

N2 - Acute lung injury (ALI) is a severe illness with excess mortality and no specific therapy. In its early exudative phase, neutrophil activation and accumulation in the lung lead to hypoxemia, widespread tissue damage, and respiratory failure. In clinical trials, inhibition of proinflammatory mediators has not proven effective. In this study, we pursued a new investigative strategy that emphasizes mediators promoting resolution from lung injury. A new spontaneously resolving experimental murine model of ALI from acid aspiration was developed to identify endogenous proresolving mechanisms. ALI increased cyclooxygenase 2 (COX-2) expression in murine lung. Selective pharmacologic inhibition or gene disruption of COX-2 blocked resolution of ALI. COX-2-derived products increased levels of the proresolving lipid mediators lipoxin A 4 (LXA4) and, in the presence of aspirin, 15-epi-LXA 4. Both LXA4 and 15-epi-LXA4 interact with the LXA4 receptor (ALX) to mediate anti-inflammatory actions. ALX expression was markedly induced by acid injury and transgenic mice with increased ALX expression displayed dramatic protection from ALI. Together, these findings indicate a protective role in ALI for COX-2-derived mediators, in part via enhanced lipoxin signaling, and carry potential therapeutic implications for this devastating clinical disorder.

AB - Acute lung injury (ALI) is a severe illness with excess mortality and no specific therapy. In its early exudative phase, neutrophil activation and accumulation in the lung lead to hypoxemia, widespread tissue damage, and respiratory failure. In clinical trials, inhibition of proinflammatory mediators has not proven effective. In this study, we pursued a new investigative strategy that emphasizes mediators promoting resolution from lung injury. A new spontaneously resolving experimental murine model of ALI from acid aspiration was developed to identify endogenous proresolving mechanisms. ALI increased cyclooxygenase 2 (COX-2) expression in murine lung. Selective pharmacologic inhibition or gene disruption of COX-2 blocked resolution of ALI. COX-2-derived products increased levels of the proresolving lipid mediators lipoxin A 4 (LXA4) and, in the presence of aspirin, 15-epi-LXA 4. Both LXA4 and 15-epi-LXA4 interact with the LXA4 receptor (ALX) to mediate anti-inflammatory actions. ALX expression was markedly induced by acid injury and transgenic mice with increased ALX expression displayed dramatic protection from ALI. Together, these findings indicate a protective role in ALI for COX-2-derived mediators, in part via enhanced lipoxin signaling, and carry potential therapeutic implications for this devastating clinical disorder.

UR - http://www.scopus.com/inward/record.url?scp=17044377563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17044377563&partnerID=8YFLogxK

M3 - Article

VL - 174

SP - 5033

EP - 5039

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -